Usefulness of pre-surgical biopsy in selecting patients with hepatocellular carcinoma for liver transplant;Utilidad de la biopsia preoperatoria en la selección de pacientes con hepatocarcinoma para el trasplante hepático

Cirugia Espanola

Volumn 87, Issue 3, 2010, Pages 133-138

  Ramos Rubio, Emilio ^a   Llado Garriga, Laura ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Hepatocellular carcinoma; Liver biopsy; Liver transplantation

Indexed keywords

BIOPSY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER TUMOR; PATHOLOGY; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS; SHORT SURVEY;

BIOPSY; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS;

EID: 77649342183     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/j.ciresp.2009.11.026     Document Type: Short Survey

References (22)

1. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrosis. N Engl J Med 1996, 334:693-699.
2. Poon R.T., Ng I.O., Lau C., Zhu L.X., Yu W., CmLo C.M., et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 2001, 233:227-235.
3. Shirabe K., Itoh S., Yoshizumi T., Soejima Y., Taketomi A., Aishima S., et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 2007, 95:235-240.
4. Marubashi S., Dono K., Nagano H., Sugita Y., Asaoka T., Hama N., et al. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation. Transpl Int 2007, 20:576-582.
5. Otto G., Herber S., Heise M., Lohse A.W., Monch C., Bittinger F., et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006, 12:1260-1267.
6. Jonas S., Bechstein W.O., Steinmüller T., Herrmann M., Radke C., Berg T., et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001, 33:1080-1086.
7. Esnaola N.F., Lauwers G.Y., Mirza N.Q., Nagorney D.M., Doherty D., Ikai I., et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002, 6:224-232.
8. Lohe F., Angele M.K., Rentsch M., Graeb C., Gerbes A., Lohrs U., et al. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: Implications for patient selection in liver transplantation. Clin Transplant 2007, 21:696-701.
9. Shah S.A., Tan J.C., McGilvray I.D., Cattral M.S., Levy G.A., Greig P.D., et al. Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants. J Gastrointest Surg 2007, 11:464-471.
10. Mazzaferro V., Llovet J.M., Miceli R., Bhoori S., Schiavo M., Mariani L., et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis. Lancet Oncol 2009, 10:35-43.
11. Parfitt J.R., Marotta P., Alghamdi M., Wall W., Khakhar A., Suskin N.G., et al. Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence. Liver Transpl 2007, 13:543-551.
12. Klintmalm G.B. Liver transplantation for hepatocellular carcinoma: A registry report of the impact of tumor characteristics on outcome. Ann Surg 1998, 228:479-490.
13. Tamura S., Kato T., Berho M., Misiakos E.P., O'Brien C., Reddy K.R., et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001, 136:25-30.
14. Cillo U., Vitale A., Bassanello M., Boccagni P., Brolese A., Zanus G., et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004, 239:150-159.
15. Stigliano R., Marelli L., Yu D., Davies N., Patch D., Burroughs A.K. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007, 33:437-447.
16. Maturen K.E., Nghiem H.V., Marrero J.A., Hussain H.K., Higgins E.G., Fox G.A., et al. Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. Am J Roentgenol 2006, 187:1184-1187.
17. Saborido B.P., Díaz J.C., de Los Galanes S.J., Segurola C.L., de Usera M.A., Garrido M.D., et al. Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma?. Transplant Proc 2005, 37:3874-3877.
18. Pawlik T.M., Gleisner A.L., Anders R.A., Assumpçao L., Maley W., Choti M.A., et al. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: Implications for transplant eligibility. An Surg 2007, 245:435-442.
19. Chua M.S., Sun H., Cheung S.T., Mason V., Higgins J., Ross D.T., et al. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 2007, 20:76-83.
20. Iizuka N., Oka M., Yamada-Okabe H., Nishida M., Maeda Y., Mori N., et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003, 361:923-929.
21. Ramos E., Llado L., Serrano T., Figueras A., Lastra R., Torras J., et al. Utility of cell-cycle modulators to predict vascular invasion and recurrence after surgical treatment of hepatocellular carcinoma. Transplantation 2006, 82:753-758.
22. Dvorchik I., Schwartz M., Fiel M.I., Finkelstein S.D., Marsh J.W. Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma. Liver Transpl 2008, 14:443-445.